Navigation Links
American Regent Resumes Shipment of Injectable Products
Date:5/6/2011

SHIRLEY, N.Y., May 6, 2011 /PRNewswire/ -- American Regent announced today that it had resumed the shipment of its multisource injectable products on May 5, 2011.  Release of products is being prioritized and American Regent is working closely with the FDA Drug Shortage Staff to ensure that supplies of critically needed medications are available for patient care.

Please Note: Products have been shipped and are available from your local Wholesaler or Distributor.

In addition to Venofer® (iron sucrose injection, USP), the following products have been released and shipped:Atropine Sulfate Injection, USPCaffeine Citrate Injection, USPChromic Chloride Injection, USPConcentrated Zinc Sulfate Injection, USPDehydrated Alcohol Injection, USPDopamine HCL Injection, USPDroperidol Injection, USPGlycopyrrolate Injection, USPHydroxyzine HCL Injection, USPIron Dextran Injection, USP (Dexferrum®)L-Cysteine HCL Injection, USPMultitrace® -4 (Trace Elements Injection 4, USP)Multitrace® -4 Concentrate (Trace Elements Injection 4, USP - Concentrate)Multitrace® -5 Concentrate (Trace Elements Injection 5, USP - Concentrate)Neostigmine Methylsulfate Injection, USP  Nitroglycerin Injection, USPPapaverine HCL Injection, USPPhenylephrine HCL Injection, USPPotassium Phosphates Injection, USPSodium Phosphates Injection, USPAmerican Regent can confirm that these products were manufactured in accordance with cGMP and quality requirements and that they meet all USP and other internal monograph and quality release specifications. American Regent is confident in the integrity and quality of these injectable products.

Visit our website at www.americanregent.com for daily updates on product releases and availability or contact our Customer Service Department at: 1-800-645-1706. We apologize for any inconvenience this temporary suspension of manufacturing and distribution has caused. We appreciate the tremendous support that our customers and partners have given us during this period and for your continued loyalty and confidence in our products.

American Regent will continue to work diligently to research, develop and supply quality injectable products, as it has done since 1967.

If you have any questions or need to place an order for an emergency "drop shipment" please contact our Customer Service Department at 1-800-645-1706 or for more information, please visit our website at: www.americanregent.com


'/>"/>

SOURCE American Regent, Inc. & Luitpold Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
2. American Pacific to Release Financial Results and Hold Fiscal 2011 Second Quarter Investor Teleconference
3. American Medical Systems GreenLight HPS® Approved for Use in Japan
4. Christiana Care Breast Center First in Delaware to Earn American College of Radiology Accreditation
5. Plato BioPharma Presenting Poster at the American Thoracic Society Conference
6. Hologic Features New Minimally Invasive Technologies at the American Congress of Obstetricians and Gynecologists Annual Meeting
7. Reportlinker Adds Latin American Markets for Dental Implants, Final Abutments and Computer Guided Surgery 2011 (Argentina, Brazil and Mexico)
8. American Regent Resumes Shipment of VENOFER® (iron sucrose injection, USP)
9. May is Older Americans Month
10. Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows
11. Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):